(Q45122740)

9 December 2017

Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat. (English)

1 reference

9 December 2017

3

1 reference

9 December 2017

5

Peter Riederer

1 reference

9 December 2017

Manfred Gerlach

1

1 reference

9 December 2017

Maarten van den Buuse

series ordinal

2

1 reference

9 December 2017

Dirk Bremen

series ordinal

4

1 reference

9 December 2017

20 October 2004

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

9 December 2017

1 reference

9 December 2017

370

1 reference

9 December 2017

5

1 reference

9 December 2017

388-394

1 reference

https://scigraph.springernature.com/pub.10.1007/s00210-004-0984-8

9 December 2017

0 references

cites work

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-004-0984-8

Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-004-0984-8

L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

1 reference

12 December 2020

Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

1 reference

12 December 2020

Improved electrochemical properties of stearate-graphite paste electrodes after albumin and phospholipid treatments

1 reference

12 December 2020

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

1 reference

12 December 2020

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

1 reference

12 December 2020

The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats

1 reference

12 December 2020

Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure

1 reference

12 December 2020

On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

12 December 2020

Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats

1 reference

12 December 2020

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

12 December 2020

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

12 December 2020

A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviours

1 reference

12 December 2020

Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain.

1 reference

12 December 2020

10.1007/S00210-004-0984-8

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference